Enanta is in a strong position to dominate the largely untapped RSV therapeutics market with a Phase III trial on the horizon ...

The CDC’s 2026 adult immunization schedule adds earlier shingles vaccination, widens RSV vaccine eligibility, and adopts an annual COVID-19 booster model. These updates respond to shifting disease ...

The Centers for Disease Control and Prevention (CDC) has expanded the RSV vaccine recommendation to include adults 50 and older who are at higher risk of severe illness. Despite the eligibility ...

ST. PETERSBURG, Fla. — While the respiratory syncytial virus, known as RSV, is often thought of as a childhood issue, experts said many overlook its impact on adults. As a result, the Centers for ...

The U.S. Food and Drug Administration expanded its approval of Moderna's respiratory syncytial virus (RSV) vaccine on Thursday to include adults under the age of 60 at increased risk of the disease.

"This study includes CDC’s first comprehensive estimates of RSV disease burden in U.S. adults, including hospitalizations and in-hospital deaths. It demonstrates that RSV caused a substantial burden ...

Respiratory syncytial virus (RSV) infections in older adults lead to significantly more severe health outcomes and long-term cardiovascular complications compared to other common causes of ...

RSV vaccination for adults aged 60+ could prevent significant LRTD cases, hospitalizations, and deaths over five years. A 5-percentage-point increase in vaccine uptake could avert over 222,000 LRTD ...

The burden of RSV-associated hospitalization was high in older adults, with the greatest risk among the oldest age strata and those with CHF.

The federal government program that already offers free jabs during pregnancy will be expanded to include over-75s, amid ...

We all know the risks of influenza and COVID for older people. But a third virus, RSV, can also land you in hospital. A free ...